Citigroup
INDP icon

Citigroup’s Indaptus Therapeutics INDP Stock Holding History

Citigroup’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2 Buy
+1
New +$2 ﹤0.01% 5911
2019
Q2 		– Hold
0
– -$2K – 7793
2019
Q1 		– Hold
0
– – – 7534
2016
Q1 		– Hold
0
– – – 7584
2015
Q4 		– Hold
0
– – – 7690

Other funds holding INDP

SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Citigroup's INDP Position: Q3 2026 in Review

Citigroup opened a new position in Indaptus Therapeutics (INDP) in Q3 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #5911 among its holdings.

3 funds tracked by Wall St. Rank hold INDP as of Q3 2026.

  • Citigroup held 1 share of Indaptus Therapeutics worth $2 as of Q3 2026.
  • Indaptus Therapeutics was a new Citigroup position in Q3 2026.
  • Indaptus Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5911 holding.
  • 3 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.